Treatment of Irritable Bowel Syndrome Using Complementary and Alternative Medicine

Journal of the Chinese Medical Association

Volumn 72, Issue 6, 2009, Pages 294-300

  Chang, Full Young ^a   Lu, Ching Liang ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

acupuncture; complementary and alternative medicine; functional gastrointestinal disorder; herbal medicine; irritable bowel syndrome

Indexed keywords

ALOE VERA EXTRACT; ANTIDIARRHEAL AGENT; BULKING AGENT; HERBACEOUS AGENT; LAXATIVE; MELATONIN; OSMOTIC AGENT; PEPPERMINT OIL; PLACEBO; PROBIOTIC AGENT; SEDATIVE AGENT; SPASMOLYTIC AGENT; TRANQUILIZER; ALUMINUM SILICATE; VEGETABLE OIL;

ABDOMINAL DISTENSION; ABDOMINAL PAIN; ACUPUNCTURE; ALOE; AROMATHERAPY; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL TRIAL; COLON LAVAGE; CONSTIPATION; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; FLATULENCE; GINGER; HERBAL MEDICINE; HOMEOPATHY; HUMAN; HYDROTHERAPY; IRRITABLE COLON; KIDNEY DISEASE; LIVER DISEASE; PATIENT SATISFACTION; PHYSICIAN; PSYCHOTHERAPY; QUALITY OF LIFE; REFLEXOLOGY; REVIEW; TREATMENT RESPONSE; ULCERATIVE COLITIS; ALTERNATIVE MEDICINE; ANIMAL; CLAY; METHODOLOGY; PHYTOTHERAPY; RELAXATION TRAINING;

ACUPUNCTURE THERAPY; ALUMINUM SILICATES; ANIMALS; COMPLEMENTARY THERAPIES; HUMANS; IRRITABLE BOWEL SYNDROME; MELATONIN; PHYTOTHERAPY; PLANT OILS; RELAXATION THERAPY;

EID: 69149094660     PISSN: 17264901     EISSN: 17287731     Source Type: Journal    
DOI: 10.1016/S1726-4901(09)70375-2     Document Type: Review

References (72)

1. Drossman D.A. The functional gastrointestinal disorders and the Rome III process. Gastroenterology 130 (2006) 1377-1390
2. Longstreth G.F., Thompson W.G., Chey W.D., Houghton L.A., Mearin F., and Spiller R.C. Functional bowel disorders. Gastroenterology 130 (2006) 1480-1491
3. Gerson C.D., Gerson M.J., Awad R.A., Chowdhury A., Dancey C., Poitras P., Porcelli P., et al. Irritable bowel syndrome: an international study of symptoms in eight countries. Eur J Gastroenterol Hepatol 20 (2008) 659-667
4. Lu C.L., Chen C.Y., Lang H.C., Luo J.C., Wang S.S., Chang F.Y., and Lee S.D. Current patterns of irritable bowel syndrome in Taiwan: the Rome II questionnaire on a Chinese population. Aliment Pharmacol Ther 18 (2003) 1159-1169
5. Talley N.J. Functional gastrointestinal disorders as a public health problem. Neurogastroenterol Motil 20 Suppl (2008) 121-129
6. Yunus M.B. Fibromyalgia and overlapping disorders: the unifying concept of central sensitive syndromes. Semin Arthritis Rheu 36 (2007) 339-356
7. Kellow J.E., Azpiroz F., Delvaux M., Gebhart G.F., Mertz H.R., Quigley F., and Smout A. Applied principles of neurogastroenterology: physiology/motility sensation. Gastroenterology 130 (2006) 1412-1420
8. Spiller R., Aziz Q., Creed F., Emmanuel A., Houghton L., Hungin P., Jones R., et al. Guidelines on the irritable bowel syndrome: mechanisms and practical management. Gut 56 (2007) 1770-1798
9. Lacy B.E., Weiser K., Noddin L., Robertson D.J., Crowell M.D., Parratt-Engstrom C., and Grau M.V. Irritable bowel syndrome: patient's attitudes, concerns and level of knowledge. Aliment Pharmacol Ther 25 (2007) 1329-1342
10. Nyrop K.A., Palsson O.S., Levy R.L., von Korff M., Feld A.D., Turner M.J., and Whitehead W.E. Costs of health care for irritable bowel syndrome, chronic constipation, functional diarrhoea and functional abdominal pain. Aliment Pharmacol Ther 26 (2007) 237-248
11. Mayer E.A. Irritable bowel syndrome. N Engl J Med 358 (2008) 1692-1699
12. Dalrymple J., and Bullock I. Diagnosis and management of irritable bowel syndrome in adults in primary care: summary of NICE guidance. BMJ 336 (2008) 556-558
13. Tack J., Fried M., Houghton L.A., Spicak J., and Fisher G. Systematic review: the efficacy of treatments for irritable bowel syndrome- a European perspective. Aliment Pharmachol Ther 24 (2006) 183-205
14. Kline K.B. Controlled treatment trial in the irritable bowel syndrome: a critique. Gastroenterology 95 (1988) 232-241
15. Lembo A. Irritable bowel syndrome medications side effects survey. J Clin Gastroenterol 38 (2004) 776-781
16. Dorn S.D., Kaptchuk T.J., Park J.B., Nguyen L.T., Canenguez K., Nam B.H., Woods K.B., et al. A meta-analysis of the placebo response in complementary and alternative medicine trials of irritable bowel syndrome. Neurogastroenterol Motil 19 (2007) 630-637
17. Hussain Z., and Quigley E.M. Systematic review: complementary and alternative medicine in the irritable bowel syndrome. Aliment Pharmacol Ther 23 (2006) 465-471
18. Chang F.Y., Lu C.L., Chen C.Y., and Luo J.C. Efficacy of dioctahedral smectite in treating patients of diarrhea-predominant irritable bowel syndrome. J Gastroenterol Hepatol 22 (2007) 2266-2272
19. Bradesi S., and Mayer E.A. Novel therapeutic approaches in IBS. Curr Opin Pharmacol 7 (2007) 598-604
20. Matsueda K., Harasawa S., Hongo M., Hiwatashi N., and Sasaki D. A randomized, double-blind, placebo-controlled clinical trial of the effectiveness of the novel serotonin type 3 receptor antagonist ramosetron in both male and female Japanese patients with diarrhea-predominant irritable bowel syndrome. Scand J Gastroenterol 43 (2008) 1202-1211
21. Smart H.L., Mayberry J.F., and Atkinson M. Alternative medicine consultations and remedies in patients with irritable bowel syndrome. Gut 27 (1986) 826-828
22. Koloski N.A., Talley N.J., Huskic S.S., and Boyce P.M. Predictor of conventional and alternative health care seeking for irritable bowel syndrome and functional dyspepsia. Aliment Pharmacol Thet 17 (2003) 841-851
23. van Tilburg M., Palsson O.S., Levy R.L., Feld A.D., Turner M.J., Drossman D.A., and Whitehead W.E. Complementary and alternative medicine use and cost in functional bowel disorders: a six month prospective study in a large HMO. BMC Complement Altern Med 8 (2008) 46-52
24. Spanie J.A., Howden C.W., and Jones M.P. A systematic review of alternative therapies in the irritable bowel syndrome. Arch Intern Med 163 (2003) 265-274
25. Langmead L., and Rampton D.S. Review article: complementary and alternative therapies for inflammatory bowel disease. Aliment Pharmacol Ther 23 (2006) 341-349
26. Herman P.M., Craaig B.M., and Caspi O. Is complementary and alternative medicine (CAM) cost-effective? A systematic review. BMC Complement Altern Med 5 (2005) 11-25
27. van der Watt G., Laugharne J., and Janca A. Complementary and alterative medicine in the treatment of anxiety and depression. Curr Opin Psychiatry 21 (2008) 37-42
28. Yang Z.C., Yang S.H., Yang S.S., and Chen D.S. A hospital-based study on the use of alternative medicine in patients with chronic liver and gastrointestinal diseases. Am J Chin Med 30 (2002) 637-643
29. Guo R., Canter P.H., and Ernst E. A systematic review of randomized clinical trials of individual herb medicine in any indication. Postgrad Med J 83 (2007) 633-637
30. Shi J., Tong Y., Shen J.G., and Li H.X. Effectiveness and safety of herb medicines in the treatment of irritable bowel syndrome: a systematic review. World J Gastroenterol 14 (2008) 454-462
31. Leung W.K., Wu J., Liang S.M., Chan L.S., Chan F.K.L., Xie H., Fung S.S., et al. Treatment of diarrhea-predominant irritable bowel syndrome with traditional Chinese herb medicine: a randomized placebo-controlled trial. Am J Gastroenterol 101 (2006) 1574-1580
32. Bensoussan A., Talley N.J., Hing M., Menzies R., Guo A., and Ngu M. Treatment of irritable bowel syndrome with Chinese herb medicine: a randomized controlled trial. JAMA 280 (1998) 1585-1589
33. Liu J.P., Yang M., Liu Y.X., Wei M.L., and Grimsqaard S. Herb medicines for treatment of irritable bowel syndrome. Cochrane Database Syst Rev (2006) CD004116.
34. Yuan R., and Lin Y. Traditional Chinese medicine: an approach to scientific proof and clinical validation. Pharmacol Ther 86 (2000) 191-198
35. Bensoussan A. Establishing evidence for Chinese medicine: a case example of irritable bowel syndrome. J Chin Med Assoc 64 (2001) 487-492
36. Yadav S.K., Jain A.K., Tripathi S.N., and Gupta J.P. Irritable bowel syndrome: therapeutic evaluation of indigenous drugs. Indian J Med Res 90 (1989) 496-503
37. Sallon S., Ben-Arve E., Dovidson R., Shapiro H., Ginsberg G., and Ligumsky M. A novel treatment for constipation-predominant irritable bowel syndrome using Padmax Lax, a Tibetan herbal formula. Digestion 65 (2002) 161-171
38. Langmead L., Feakins R.M., Goldthorpe S., Holt H., Tsironi E., De Silva A., Jewell D.P., et al. Randomised double-blind, placebo-controlled trial of oral aloe vera gel for active ulcerative colitis. Aliment Pharmacol Ther 19 (2004) 739-747
39. Davis K., Philpott S., Kumar D., and Mendall M. Randomised doubleblind placebo-controlled trial of aloe vera for irritable bowel syndrome. Int J Clin Pract 60 (2006) 1080-1086
40. Takahashi T. Acupuncture for functional gastrointestinal disorders. J Gastroenterol 41 (2006) 408-417
41. Sung J. Acupuncture for gastrointestinal disorders: myth or magic. Gut 51 (2002) 617-619
42. Ouyang H., and Chen J.D.Z. Review article: therapeutic roles of acupuncture in functional gastrointestinal disorders. Aliment Pharmacol Ther 20 (2004) 831-841
43. Xiao W.B., and Liu Y.L. Rectal hypersensitivity reduced by acupoint TENS in patients with diarrhea-predominant irritable bowel syndrome: a pilot study. Dig Dis Sci 49 (2004) 312-319
44. Chan J., Carr I., and Mayberry J.F. The role of acupuncture in the treatment of irritable bowel syndrome: a pilot study. Hepatogastroenterology 44 (1997) 1328-1330
45. Huang Z.D., Liang L.A., and Zhang W.X. Acupuncture combined with massage for treatment of irritable bowel syndrome. Zhongguo Zhen Jiu 26 (2006) 717-718
46. Fireman Z., Segal A., Kopelman Y., Sternberg A., and Carasso R. Acupuncture treatment for irritable bowel syndrome. A doubleblind controlled study. Digestion 64 (2001) 100-103
47. Forbes A., Jackson S., Walter C., Queraishi S., Jacyna M., and Pitcher M. Acupuncture for irritable bowel syndrome, a doubleblind placebo-controlled trial. World J Gastroenterol 11 (2005) 4040-4044
48. Lim B., Manhimer E., Lao L., Ziea E., Wisniewski J., Liu L., and Berman B. Acupuncture for treatment of irritable bowel syndrome. Cochrane Database Syst Rev (2006) CD005111.
49. Pittler M.H., and Ernst E. Peppermint oil for irritable bowel syndrome: a critical review and metaanalysis. Am J Gastroenterol 93 (1998) 1131-1135
50. Hills J.M., and Aaronson P. The mechanism of action of peppermint oil on gastrointestinal smooth muscle. Gastroenterology 101 (1991) 55-65
51. Kligler B., and Chaudhary S. Peppermint oil. Am Fam Physician 75 (2007) 1027-1030
52. Grigoleit H.G., and Grigoleit P. Peppermint oil in irritable bowel syndrome. Phytomedicine 12 (2005) 601-606
53. Liu J.H., Chen G.H., Yeh H.Z., Huang C.K., and Poon S.K. Enteric coated peppermint oil capsules in the treatment of irritable bowel syndrome: a prospective, randomized trial. J Gastroenterol 32 (1997) 765-768
54. Cappello G., Spezzaferro M., Grossi L., Manzoli L., and Marzio L. Peppermint oil (Mintoil®) in the treatment of irritable bowel syndrome: a prospective double blind placebo-controlled trial. Dig Liver Dis 39 (2007) 530-536
55. Richardson G.S., Mitrzyk B.M., and Bramley T.J. Circadian rhythmicity and the pharmacologic management of insomnia. Am J Manag Care 13 (2007) S125-S128
56. Bubenik G.A. Gastrointestinal melatonin: localization, function, and clinical relevance. Dig Dis Sci 47 (2002) 2336-2348
57. Bubenik G.A., and Dhanvantari S. Influence of serotonin and melatonin on some parameters of gastrointestinal activity. J Pineal Res 7 (1989) 333-344
58. Song G.H., Leng H., Gwee K.A., Moochhala S.M., and Ho K.Y. Melatonin improves abdominal pain in irritable bowel syndrome patients who have sleep disturbances: a randomized, double blind, controlled study. Gut 54 (2005) 1402-1407
59. Lu W.Z., Gwee K.H., Moochhalla S., and Ho K.Y. Melatonin improves bowel symptoms in female patients with irritable bowel syndrome: a double-blind placebo-controlled study. Aliment Pharmacol Ther 22 (2005) 927-934
60. Saha L., Malhotra S., Rana S., Bhasin D., and Pandhi P. A preliminary study of melatonin in irritable bowel syndrome. J Clin Gastroenterol 41 (2007) 29-32
61. Taffinder N.J., Tan E., Webb I.G., and McDonald P.J. Retrograde commercial colonic hydrotherapy. Colorectal Dis 6 (2004) 258-260
62. Pizzetti D., Annibali R., Bufo A., and Pescatori M. Colonic hydrotherapy for obstructed defecation. Colorectal Dis 7 (2005) 107-108
63. Shevchuk N.A. Hydrotherapy as a possible neuroleptic and sedative treatment. Med Hypotheses 70 (2008) 230-238
64. Ratnaraja N., and Raymond N. Extensive abscesses following colonic hydrotherapy. Lancet Infect Dis 5 (2005) 527
65. Tan M.P., and Cheong D.M. Life-threatening perineal gangrene from rectal perforation following colonic hydrotherapy: a case report. Ann Acad Med Singapore 28 (1999) 583-585
66. Tovey P. A single-blind trial of reflexology for irritable bowel syndrome. Br J Gen Pract 52 (2002) 19-23
67. van der Veek P.P., van Rood Y.R., and Masclee A.A. Clinical trial: shortand long-term benefit of relaxation training for irritable bowel syndrome. Aliment Pharmacol Ther 26 (2007) 943-952
68. Madkour A.A., Madina E.M., el-Azzouni O.E., Amer M.A., el-Walili T.M., and Abbass T. Smectite in acute diarrhea in children: a double-blind placebo-controlled clinical trial. J Pediatr Gastroenterol 17 (1993) 176-181
69. Szajewska H., Dziechciarz P., and Mrukowicz J. Meta-analysis: smectite in the treatment of acute infectious diarrhoea in children. Aliment Pharmacol Ther 23 (2006) 217-227
70. Yao-Zong Y., Shi-Rong L., and Delvaux M. Comparative efficacy of dioctahedral smectite (Smecta) and a probiotic preparation in chronic functional diarrhoea. Dig Liver Dis 36 (2004) 824-828
71. Martirosian G., Rouyan G., Zalewski T., and Meisei-Mikoajczyk F. Dioctahedral smectite neutralization activity of Clostridium difficile and Bacteroides fragilis toxins in vitro. Acta Microbiol Pol 47 (1998) 177-183
72. Ducrotte P., Dapoigny M., Bonaz B., and Siproudhis L. Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial. Aliment Pharmacol Ther 21 (2005) 435-444